The increasing burden of NAFLD fibrosis in the general population: Time to bridge the gap between hepatologists and primary care
Marloes van Asten, Pauline Verhaegh, Ger Koek, Jef Verbeek – 10 November 2016
Percutaneous creation of biliary‐enteric neoanastomosis for anastomotic biliary occlusion following living donor liver transplantation
Colin J. McCarthy, Ashraf Thabet, Kei Yamada, Peter R. Mueller, Parsia A. Vagefi – 10 November 2016
Opciones terapéuticas para los pacientes con hepatitis C crónica y fracaso terapéutico previo
Neil D. Shah, Michael W. Fried – 10 November 2016
Vigilancia del colangiocarcinoma en pacientes con colangitis esclerosante primaria: ¿es efectiva y está justificada?
Nataliya Razumilava, Gregory J. Gores – 10 November 2016
Lipid and copper metabolism in humans with wilson disease: Enigmatic relationship
Palittiya Sintusek, Anil Dhawan – 10 November 2016
Longterm renal allograft survival after sequential liver‐kidney transplantation from a single living donor
Kumiko Kitajima, Yuichi Ogawa, Katsuyuki Miki, Kotaro Kai, Akihito Sannomiya, Kazuhiro Iwadoh, Toru Murakami, Ichiro Koyama, Ichiro Nakajima, Shohei Fuchinoue – 10 November 2016 – Combined liver‐kidney transplantation (CLKT) is well established as a definitive therapy with the potential to provide complete recovery for certain liver‐kidney diseases, although the results might be contingent on the cause of transplantation.
¿Qué es la hipertensión portal no cirrótica idiopática?
Guadalupe García‐Tsao – 10 November 2016
Daño hepático debido al uso de suplementos nutricionales y de herbolario: revisión de componentes individuales
Elizabeth Zheng, Víctor Navarro – 10 November 2016
Effects of recipient size and allograft type on pediatric liver transplantation for biliary atresia
Sophoclis P. Alexopoulos, Victor Nekrasov, Shu Cao, Susan Groshen, Navpreet Kaur, Yuri S. Genyk, Lea Matsuoka – 10 November 2016 – The majority of pediatric patients with end‐stage liver disease receive a transplant with a whole liver (WL) allograft. However, smaller recipients with biliary atresia (BA) may have improved outcomes with deceased donor partial liver (DDPL) or living donor allografts. This study compares the national outcomes for liver transplantation in BA, with attention to the interaction between liver allograft type and recipient size.